Strength
.25 mg/1
Manufacturer
AvPAKNDC
50268074115
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078110On Market Since
8/19/2022
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 0.25 MG TABLET has been published 176 times since Feb 15, 2023, and over the history we have for it it has risen 2.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0462 per EA |
|---|---|
| All-time high | $0.0520 (Feb 14, 2024) |
| All-time low | $0.0347 (Nov 20, 2024) |
| 52-week high | $0.0476 |
| 52-week low | $0.0462 |
| Median price | $0.0474 |
| Average price | $0.0469 |
| Largest weekly change | -28.4% (Nov 20, 2024) |
| Weeks tracked | 176 |
| Tracking since | Feb 15, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 0.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 0.25 MG TABLET, manufactured by AvPAK, is $0.0462 per EA (NDC 50268074115), effective Jun 24, 2026.
How has the price of ROPINIROLE HCL 0.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 0.25 MG TABLET has risen 2.3%. It has been tracked across 176 weekly CMS publications since Feb 15, 2023.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 0.25 MG TABLET?
Since Feb 15, 2023, the NADAC for ROPINIROLE HCL 0.25 MG TABLET has ranged from a low of $0.0347 (Nov 20, 2024) to a high of $0.0520 (Feb 14, 2024), with a median of $0.0474 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 0.25 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ROPINIROLE HCL 0.25 MG TABLET, but none are currently priced below it.
Who manufactures ROPINIROLE HCL 0.25 MG TABLET?
ROPINIROLE HCL 0.25 MG TABLET (NDC 50268074115) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification